EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022
Edwards Lifesciences (NYSE: EW) will announce its operating results for Q1 2022 after market close on April 26, 2022. A conference call to discuss these results is scheduled for 5:00 p.m. ET on the same day. Edwards Lifesciences is recognized for its innovations in structural heart disease and critical care monitoring. Investors can participate by dialing (877) 704-2848 or (201) 389-0893, and the call will also be streamed live on the company’s Investor Relations webpage.
- None.
- None.
IRVINE, Calif., April 19, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday, April 26, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the "Investor Relations" section of the Edwards website at ir.edwards.com.
About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-host-earnings-conference-call-on-april-26-2022-301527705.html
SOURCE Edwards Lifesciences Corporation
FAQ
When will Edwards Lifesciences announce Q1 2022 results?
What time is the Edwards Lifesciences earnings conference call?
How can I participate in the Edwards Lifesciences conference call?